Prices delayed by at least 15 minutes | Print
Vanguard Health Care Etf VANGUARD HEALTH CARE INDEX FUND ETF
Open
Previous close
Trade high
Income frequency
-
Year low
Year high
Replication method
Physical Full
Volume
0
Type
ETF
UCITS
No
Dividend yield
1.16%
Ongoing charge
-
ISIN
US92204A5048
Share price
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Eli Lilly and Co | 14.66 |
| Johnson & Johnson | 8.38 |
| AbbVie Inc | 6.73 |
| UnitedHealth Group Inc | 4.78 |
| Merck & Co Inc | 4.77 |
| Thermo Fisher Scientific Inc | 3.35 |
| Amgen Inc | 3.25 |
| Gilead Sciences Inc | 2.74 |
| Abbott Laboratories | 2.39 |
| Pfizer Inc | 2.25 |
Investment objective
The investment seeks to track the performance of the MSCI U.S. Investable Market Index (IMI)/Health Care 25/50. The fund employs an indexing investment approach designed to track the performance of the index, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the GICS. The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.